approval
saveEPYSQLI (ECULIZUMAB-AAGH) — FDA approval
community read0 votes
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTION. Route: SOLUTION
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 8
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJan 23, 2026 · 301d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalNov 28, 2025 · 357d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalNov 10, 2025 · 375d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalSep 2, 2025 · 444d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalApr 30, 2025 · 569d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalMar 12, 2025 · 618d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJan 28, 2025 · 661d ago
- approvalEPYSQLI (ECULIZUMAB-AAGH) — FDA approvalNov 15, 2024 · 735d ago
same company · ±60 days · 6
- approvalEPYSQLI: EPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJan 28, 2025
- approvaldenosumab biosimilar: DENOSUMAB-DSSB — FDA approvalFeb 13, 2025
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalDec 20, 2024
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalDec 20, 2024
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalDec 20, 2024
- approvalONTRUZANT: ONTRUZANT (TRASTUZUMAB-DTTB) — FDA approvalFeb 28, 2025
comments(0)
5-min edit window · permanent after that